Macdermol® is a brand from Astagen® Therapeutics - A french origine health care company that discovers, develops and manufactures innovative products useful in the prevention and treatment of aging processes.

Through a combination of internal product development, product/business acquisition, and distribution agreements, we bring to market products which address a growing need for clinically effective, cost-efficient, minimally invasive medical treatments that protect and regenerate connective tissue.

Established in 2008, Astagen is headquartered in the United Kingdom and has manufacturing and research locations in France, England, and Ireland.

About Astagen

We are focused on research to discover, develop and deliver innovative new therapies. We have a particular interest in the various structural modifications occurring in connective tissue and induced by time, environment, daily stress and mechanical constraints. We’re constantly working to create solutions that prevent and correct these tissue degenerations.

Astagen® Brand Portfolio